BioSight
Companies
CapsoVision, Inc logo

CV

NASDAQSARATOGA, CA
CapsoVision, Inc

CapsoVision develops ingestible capsule cameras for gastrointestinal imaging, with its lead product CapsoCam Plus cleared for small bowel visualization and CapsoCam Colon pending FDA clearance for colon imaging. The company is in the commercialization stage, recently expanding its small bowel capsule into pediatric use and telehealth applications while developing AI-enhanced imaging capabilities and pursuing additional GI indications.

Price history not yet available for CV.

Pipeline

No pipeline data on record yet.

Catalyst Calendar

No catalyst events on record for yet. Check back after the next daily ingest.

Disclaimer·BioSight aggregates publicly available data (SEC EDGAR, ClinicalTrials.gov, FDA, company press releases) and is provided as is for informational purposes only. Nothing here is investment, financial, legal, tax, or medical advice, or an offer to buy or sell any security. We make no warranty as to accuracy, completeness, or timeliness; dates and filings may contain errors or be superseded without notice; past events do not predict future outcomes. To the maximum extent permitted by law, BioSight, its operators, contributors, and affiliates disclaim all liability for any loss or damage arising from use of or reliance on this site. You are solely responsible for your own investment decisions — consult a licensed professional before acting on any information.

Unlock 12-month calendar